chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Immediately after receiving vaccine, patient felt dizzy but waited 15 minutes and felt ok to drive home.  Upon arriving home, she felt sensation of weakness on her left side.  She stated that her vision was somewhat impaired and that she felt weak, although able to move her arms and legs.   This lasted for around one hour.  She also started to have symptoms of fatigue, stiffness of neck and shoulders(bilaterally), chills, tightness of the upper back and chest but no shortness of breath noted.  These symptoms  continue.  She went to an urgent care office on 6/11/21 and was diagnosed with a sinus infection.  No lab work or medical tests were performed.   She was prescribed Augmentin and finished full regimen of medication.  The symptoms of fatigue, stiffness of neck and shoulders(bilaterally), chills, tightness of the upper back and chest continue today.
Faitgue, malaise, fever, joint pain, arm is red, swollen, and painful to touch.
Information has been received from a pharmacist referring to a 3 days old male patient. There was no information about the patient's concurrent condition and concomitant medication. On an unknown date (reported as "when he was two days old"), the patient was vaccinated with a dose of RECOMBIVAX HB when he was three days old. Lot # L039660 with expiration date 20-FEB-2018 was provided but the pharmacist could not state whether this lot was administered as the first or second dose. No adverse effects were reported. Additional information is not expected as no contact consent was given.
nausea; Headache; Fatigue; different feeling than what he normally feels; His arm was sore; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration, administered in right arm on 23Feb2021 14:02 (at the age of 76-year-old) (Batch/Lot Number: EN6202; Expiration Date: 30Jun2021) as 2ND DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included diabetes from 1996. The patient's concomitant medications were not reported. Historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN9264) administered in the right arm on 02Feb2021 (at the age of 76-year-old) as 1ST DOSE, SINGLE DOSE for covid-19 immunization where patient also experienced his arm was sore. On 24Feb2021, the patient experienced nausea, headache, fatigue, different feeling than what he normally feels, and his arm was sore. The onset time for the events headache and nausea was at 09:00. The patient was admitted to the hospital due to the events nausea, headache, fatigue, and different feeling than what he normally feels. The events did not require emergency room and physician office visit. There was no treatment received for all events. On an unspecified date, the patient recovered from all events.  Follow-up attempts are needed. Further information has been requested.
Very fast heartbeat; Left side of throat and tongue was numb; Left side of throat and tongue was numb; Felt like she had difficulty breathing; Got nervous; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Very fast heartbeat), HYPOAESTHESIA ORAL (Left side of throat and tongue was numb), PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb), DYSPNOEA (Felt like she had difficulty breathing) and NERVOUSNESS (Got nervous) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced HEART RATE INCREASED (Very fast heartbeat), HYPOAESTHESIA ORAL (Left side of throat and tongue was numb), PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb), DYSPNOEA (Felt like she had difficulty breathing) and NERVOUSNESS (Got nervous). On 10-Mar-2021, HEART RATE INCREASED (Very fast heartbeat) and DYSPNOEA (Felt like she had difficulty breathing) had resolved. At the time of the report, HYPOAESTHESIA ORAL (Left side of throat and tongue was numb) and PHARYNGEAL HYPOAESTHESIA (Left side of throat and tongue was numb) outcome was unknown and NERVOUSNESS (Got nervous) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not provided.
According to patient: fever of 100-101. Flu like symptoms, GI problems, tiredness.
Arms bilaterally warm to touch and itchy (upper arms). Evaluated by Dr. 06/19/17, MOTRIN and BENADRYL advised for symptoms.
Arm swollen from shoulder to elbow- severe swelling (looked like "Popeye").  Swelling continued for 3 days.  Red skin shoulder to elbow.  Then turned yellow after 3-4 days.  Painful to the touch.  Stiff arm, lack of flexibility.  Itching.
The patient came in for a booster shot; they received the BioNTech instead of the Bivalent for their booster.
No additional AE reported; an 11 year old patient was administered his first dose of GARDASIL 9 on 8AUG2020/ the patient has come into the pharmacy today, 20JUL2021, to receive the second dose; This spontaneous report was received from a pharmacist and refers to a 11 years old patient of unknown gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.     On 08-AUG-2020, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) 0.5 milliliter for prophylaxis (anatomical location, route of administration, lot # and expiration date were not reported). On 20-JUL-2021, the patient has come into the pharmacy to receive the second dose. No additional adverse event reported.
Urticaria on upper body (torso and arms) within 15 minutes of immunization.   Gave 25mg Beanadryl.
Fever of 101 for a day, then 99 the following day. Fever went away on day 3.; Body aches for over 2 days; Severe tiredness for 3 days; Migraine on lower right side back head / upper neck that lasted 2 days.  Migraine pain stillcomes and goes.; Migraine pain was severe enough to cause vomiting.; Muscles still sore in area of migraine 3 days after vaccine.; Sharp pulsing pain on upper left side of chest near heart.  Pain would come and go.; Pain significant enough that caused my body to cough when I felt it; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER-8727), via an unspecified route of administration in the left arm on 06Apr2021 at 11:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 23:00, the patient experienced fever of 101 for a day, then 99 the following day which went away on day 3, body aches for over 2 days, severe tiredness for 3 days after vaccine. Migraine on lower right side back head / upper neck that lasted 2 days, migraine pain was severe enough to cause vomiting, muscles still sore in area of migraine 3 days after vaccine. Migraine pain still comes and goes. For 2 days after shot, sharp pulsing pain on upper left side of chest near heart. Pain would come and go. Pain significant enough that caused the patient's body to cough when he felt it. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. On06Apr2021 at 23:00, the patient underwent lab test and procedure which included body temperature and result was shown as 101 and on 07Apr2021, the patient underwent lab test and procedure which included body temperature and result was shown as 99. The clinical outcome of fever was resolved on 08Apr2021 and  the clinical outcome of body aches was recovered on 07Apr2021. The clinical outcome of the events severe tiredness for 3 days after vaccine now, migraine on lower right side back head/ upper neck that lasted 2 days, migraine pain was severe enough to cause vomiting, muscles still sore in area of migraine 3 days after vaccine, migraine pain still comes and goes, sharp pulsing pain on upper left side of chest near heart, pain would come and go and pain significant enough that caused the patient's body to cough when he felt it were recovering at the time of reporting.   No follow-up attempts are needed. No further information is expected.
Patient's left arm became sore and painful the day after the injection.  She came into clinic today 8/27/19 with a 3X1cm lump on left arm where she received the HPV and Menactra injections.   It is slightly pink.  It is only painful when she pushes on it or lays on it.  It is not warm to touch, does not show any signs of infection.   Mom said that she did get a bit sweaty a few days after the injection, but never took her temperature.
Infant was found by mother to be unresponsive, cool to the touch, and pale. The episode lasted approximately six minutes. Pt was taken to ER, not treatment required. Pt was dx with hyporesponsive episode.
Patient is 36 weeks pregnant, has not had any adverse event so far. We are putting in a VEARS due to the fact AREXVY has not been studied to be safe in pregnant women, only the ABRYSVO. She spoke with her Obstetrician and apparently the biggest risk is preterm delivery but since she is 36 weeks, she is past that risk. There are no recommendations to revaccinate at this point, she was told they would vaccinate the baby after birth if needed.
Initial report received on 24 August 2007 from a health care professional. A four-year-old male patient, with no illness at the time of vaccination, had received a left deltoid, intramuscular injection of Daptacel, lot number C2657AA; a left deltoid, intramuscular injection of IPOL, lot number Z0873 (not a valid Sanofi Pasteur lot number); a left forearm administration of Tubersol 5 TU, lot number C2670AA; and a right deltoid, intramuscular injection of Varivax, manufacturer Merck, lot number 1015U; on 17 August 2007. The following day, the patient developed cellulitis from his left wrist to mid chest with macules and papules. He was examined by a physician two days later. Diagnostic testing was none. Treatment included Benadryl, Tylenol and Motrin as needed. Ice packs were applied intermittently. Recovery status was reported as unknown.
Pt said had big rash and pain and soreness and said pain in armpit and pt said it is getting better will call Dr and she will call Dr as well.
Merck Vaccine Representative called on behalf of physician to report a patient who received GARDASIL 9 over a year ago began having chest pain and became lightheaded and pale immediately after receiving the injection. Physician reported they laid pat; Merck Vaccine Representative called on behalf of physician to report a patient who received GARDASIL 9 over a year ago began having chest pain and became lightheaded and pale immediately after receiving the injection. Physician reported they laid pat; Merck Vaccine Representative called on behalf of physician to report a patient who received GARDASIL 9 over a year ago began having chest pain and became lightheaded and pale immediately after receiving the injection. Physician reported they laid pat; This spontaneous report was received from Physician and refers to a 12-year-old male.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On an unknown date, the patient started therapy with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, 1 dose, administered intramuscularly for prophylaxis (strength, lot #, and expiry date were not provided).  On an unknown date, Merck Vaccine Representative called on behalf of physician to report a patient who received hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) over a year ago began having chest pain and became lightheaded and pale immediately after receiving the injection. Physician reported they laid patient down and gave him oxygen and he had recovered after 45 minutes. Limited patient demographic information available. No further information provided. Merck Vaccine Representative stated she learned of this less than 24 hours ago. No additional AE/no PQC. Treatment for events were given. On an unknown date, the patient recovered from the events of chest pain, lightheaded and pale. The action taken with GARDASIL 9 regarding chest pain, lightheaded and was reported as Not Applicable.   The causal relationship between chest pain, lightheaded and and hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) was unknown.
I was prescribed PAXLOVID which I took for 5 days. Afterwards I tested negative for 3 days on AMIGEN test which I was worse & was out for 3 weeks. I had a head cold; running nose & very minimal symptoms. I still have the cough & brain fade.
This spontaneous report as received from a certified medical assistant (C.M.A.) refers to an unspecified number of patients of unknown age and gender. Medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored doses of M-M-R II (lot# K021151, expiration date 02-NOV-2016, dose and route of administration were not provided). No adverse effects were reported. This is one of two reports received from the same reporter. Additional information has been requested.
Patient complained of tingling all over the body and shakiness.  30 observation performed.  VS BP 148/70, P 80, O2Sat 98%.  Patient verbalized relief of symptoms after sit down calmly and performed deep breathing.
On August 19, 2007, patient sarted the Rabies Vaccine series.  She received Rabies Immune Globuline (Human), HyperRAB S/D and the first injection of IMOVAX Rabies Vaccine.  During the course of the 28 days when receiving the additional vaccine injections, She became increasingly fatigued and revved up (restless).  Her mental processing decreased, for example a simple math problem became to much to do.  Her arms and legs started to tingle and burn, she had muscle cramping also. As the week progressed, she felt like she was getting a bad flu.  She could not accomplish normal chors and activities.  By about one week (day 35 from the beginning of the rabies vaccine series) after the last vaccine injection she could barely get out of bed. She was bedridden for about 6 weeks. She is currently seeking medical advice.  She had a CT scan of her brain,the results normal. She has had extensive blood work, all normal.                                                                     Can you help with which course of action to take.
Feeling extremely weak approximately 9 hours after and the following day.; Slight discomfort at the injection site; Swelling of the upper arm area; This is a spontaneous report from a non-contactable consumer, the patient. A 40-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03Mar2021 at 10:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had known allergies to penicillin and shellfish.  Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. The patient did not take any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. The patient previously received neomycin sulfate; polymyxin b sulfate; bacitracin (NEOSPORIN) and experienced drug allergy. On 03Mar2021 at 20:00 the patient felt extremely weak approximately 9 hours after and the following day. Slight discomfort at the injection site with noticeable swelling of the upper arm area. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events felt extremely weak, slight discomfort at the injection site and swelling of the upper arm area was recovering at the time of this report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a pharmacist via Public Field Employee refers to a female patient of unknown age. The patient's pertinent medical history and drug reactions/allergies were unspecified by the reporter. On an unknown date the patient was vaccinated with ZOSTAVAX single administration, injection route of administration (dose, lot#, anatomical site not reported). No concomitant medications were reported. On an unknown date, reported as four weeks later after administration of the vaccine, the patient experienced pain (disability), swelling and a hard lump at the injection site. The pain and discomfort (disability), reportedly limits mobility in the arm area (disability). The patient sought medical attention (returned to the pharmacist). The outcomes of the events were reported as not recovered/not resolved. Upon internal review the events pain and discomfort reportedly limits mobility in the arm was considered as serious due to disability. Additional information has been requested.
Approximately 10 minutes after getting my 1st shot of the Pfizer Covid 19 vaccine I started to feel dizzy. I drank some water, alerted the vaccinator who asked me to stay 15 minutes later and gave me some crackers. After 15 minutes I felt better and left. Last evening I noticed some dizziness that went away. This morning I woke up I was achey, my arm was sore, dizzy and extremely fatigued. Luckily I work at home and have been able to rest. Advil has helped but I?m still very tired and arm is still sore
This spontaneous report as received from registered nurse refers to an unspecified patient of an unknown age and unknown gender. On an unknown date in 2015 (reported as past week), the unspecified patients were vaccinated with improperly GARDASIL (Lot# K007828 and expiry date:02-MAR-2017) (dose, frequency and route were not reported). No adverse effects were reported. No product quality complaint (PQC) was reported for GARDASIL. This is one of the several reports from the same reporter. Additional information is not expected as the reporter did not wish to contact.
Nausea, Fever, Pain Severed tendon, sepsis, MERSA Loss of Mobility, loss of cognitive skills, Change of personality.
Patient reported soreness/pain for 36 hours at injection site; VARIVAX administered in 2018 PROQUAD administered March 2020 PROQUAD administered March 2022 PROQUAD administered AUG 2022; VARIVAX administered in 2018 PROQUAD administered March 2020 PROQUAD administered March 2022; This spontaneous report was received from a medical assistant and refers to a 5-year-old patient of unspecified gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date in 2018, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) (lot #, expiry date, anatomical location and route of administration were not provided) administered as prophylaxis. On an unknown date in March 2020, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #, expiry date, anatomical location and route of administration were not provided) administered as prophylaxis. Then, on an unspecified date in March 2022, the patient received another dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #, expiry date, anatomical location and route of administration were not provided) administered as prophylaxis (extra dose administered). Later, on an unknown date in August 2022 the patient received another dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot #, expiry date, anatomical location and route of administration were not provided) administered as prophylaxis (extra dose administered).  On an unknown date, the patient experienced soreness/pain for 36 hours at injection site (vaccination site pain). The outcome of the event was not reported.   The causal relationship between vaccination site pain and varicella virus vaccine live (oka/merck) (VARIVAX) was not reported. The causal relationship between vaccination site pain and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was not reported.
Vaccination status - pfizer x3, moderna x1 BRIEF OVERVIEW: Discharge Provider:  MD Primary Care Provider:  DO Admission Date: 10/12/2022 Discharge Date: Oct 29, 2022   Active Hospital Problems   Diagnosis Date Noted POA ? Multiple comorbid conditions 10/24/2022 Unknown ? Goals of care, counseling/discussion 10/24/2022 Unknown ? Late onset Alzheimer's dementia without behavioral disturbance   01/04/2022 Yes DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia  [J96.01] Urinary tract infection associated with indwelling urethral catheter, initial encounter  [T83.511A, N39.0]   HOSPITAL COURSE: Patient is a 89 y.o. male with PMH of metastatic prostate cancer and urinary retention with chronic Foley catheter for which he follows with Urology, CKD3, Alzheimer's dementia, CIPD, and NIDDM2 who presented for altered mental status.  He recently had a court appointed guardian.  Patient was reportedly diagnosed with COVID-19.  He was having intermittent high fevers, lethargy, hallucinations, confusion, and cough.  This was likely the source of patient's encephalopathy.  After admission and with IV fluids, patient's mentation quickly improved back to baseline.   Of note, guardian recently became patient's guardian about a week prior to admission due to concerns with the management of his care. He was recently moved from Place to apartment complex which reportedly has 24 hour care.  Guardian is very concerned that he is unsafe living living here in that they are not actually able to provide the amount of care that he needs.  She has called for emergency hearing to get him moved back to place.   Patient's clinical condition slowly decline.  Patient was needing assistance than initially thought.  Patient was also jerky movements for which was consulted due to concern for seizures.  Seizures were ruled out.  Palliative Care was consulted for goals of care discussion. Hospice was consulted for informational visit. Guardian of patient made decision to discharge patient with hospice. Pt will be discharged back to facility under hospice care.
Patient received flu vaccine 10-11-08 and began running a fever 10-12-08 PM to 104. Patient was seen in office 10-13-08 ad had febrile sz. Pt was transported to hospital and received abx inj 10-14-08 after BC (+).
4/29 9-year-old with significant medical history including infantile spasms, seizures, hydrocephalus status post shunt insertion who presents with fever and dehydration.  Symptoms ongoing for past 3 days.  Progressed to/and tolerating full feeds, voiding/stooling on own, medically stable for discharge.
Mild redness and edema at injection site. Employee stated she had had similar reactions to the Influenza vaccine. She stated she was allergic to eggs. Recommended ibuprofen, ice to injection site, and 25-50 mg of Diphenhydramine